According to Regeneron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$18.36 Billion. In 2023 the company made a revenue of S$17.32 Billion an increase over the revenue in the year 2022 that were of S$16.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.